Long for a Longtime or until they make me an offer I cant' Refuse
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Bottom line is when it comes to the ad 2/3 trial, the good doctor is stacking the deck
I think this is what will presented at ctad
This is the first in a line of PRs that will crush the shorts an shut up the AFs of the world... JMHO
News PK/PD announced https://ih.advfn.com/p.php?pid=nmona&article=75847828
To give the shorts a chance to cover... He is a nice guy.
A reminder... we don't have to cure it! We just need to be better than DZ.
I am afraid you are right. BP still controls the politicians .... follow the $$$$.
750 would put bookends in place.
And they say the Good Doctor doesn't communicate.
“We look forward to initiating these placebo-controlled clinical trials. The respective trial designs are based on broad genomic and biomarker characterization, pharmacokinetic and pharmacodynamic modeling including data from patients in previous ANAVEX™ 2-73 trials, as well as preclinical translational science. To our knowledge, this is the first use of this approach in the design of clinical trials for Alzheimer’s disease, Parkinson’s disease and Rett syndrome, and marks a shift towards advancing implementation of precision medicine for these and other neurodegenerative and neurodevelopmental diseases.”
The Good Doctors words.
Our FDA insider talking about the FDA and Anavex is what I want to hear.
You are missing the strong possibility that Anavex will be one of the benchmark trials for CNS diseases.
You are too easy!!!
Departure of Directors or Certain
Effective as of October 1, 2017, Anavex Life Sciences Corp., a Nevada corporation (the Company), entered into an Amended and Restated Employment Agreement (the Amended Agreement) with Sandra Boenisch, in her continuing capacity as Principal Financial Officer of the Company. The Amended Agreement replaces the prior employment agreement with Ms. Boenisch, dated September 17, 2015 (the Original Agreement), which expired as of October 1, 2017.
The Amended Agreement provides for a base salary of $120,000 CAD and clarifies certain of Ms. Boenischs duties to the Company, but is otherwise materially similar to the Original Agreement. The Original Agreement is filed as Exhibit 10.92 to the Companys Annual Report on Form 10-K, filed on December 29, 2015 and is incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ANAVEX LIFE SCIENCES CORP.
/s/ Christopher Missling
Name: Christopher Missling, PhD
Title: Chief Executive Officer
Date: October 6, 2017
Based on history, it is a good thing..
And the beat goes on!!!
https://ih.advfn.com/p.php?pid=nmona&article=75806668
Anavex 2-73 has a bit more credibility since then, we have the $$$ and don't forget we are partnered with the Rett organization.
Investor2014 seems to have more incite into this. I have not completely researched the subject. But will.
Editing the genome is closer than most people think.
Check out CRISPR.
I do believe you are wrong. The company has control over when the trials are posted.
Show me were they haven't filed.
I believe the Good Doctors plan all along was to make sure all his ducks are in a row before he released any data. CTAD will hopefully give us a bash proof bunch of PR's.
last time it was 20 days
They should have a good sampling of dose optimized data to present
@ 13:15:01 375 shares went by at 4.3235..
History repeating... this time will be a different ending. IMO
My speculation.... CTAD will be the biggy!
* PK/PD data
* Phase 2/3 precision designed plan
* IND's ....Ect
can anybody Add to the list.
Looks like we will have our 15 min. of fame.
Too many hedge fund crooks controlling the stock
3:15 - 4:15 Late Breaking Communications
http://www.ctad-alzheimer.com/oral-communications-saturday-november-4
The Good Doctor is playing with the shorts... when will he stop buying????
CTAD is my target (Nov 4th) .... IMO
So I may have been right!
I love a good conspiracy. I still stand by my NDA theory.
Doesn't have to be BIIB. I do agree it is kind of strange.
Really! where is that written. Pre clinical results on MS were pretty strong. Give me another explanation.
Do some reading before you make false statements... https://www.sec.gov/rules/final/33-7881.htm
Could it be that Anavex is under a NDA when it comes to MS? Just asking...